Advertisement

Dexamethasone versus betamethasone for preterm birth: a systematic review and network meta-analysis

Published:January 19, 2021DOI:https://doi.org/10.1016/j.ajogmf.2021.100312

      Objective

      This study aimed to evaluate the comparative clinical effectiveness and safety of dexamethasone vs betamethasone for preterm birth.

      Data Sources

      The sources searched were MEDLINE, EMBASE, Cochrane Library, LILACS, ClinicalTrials.gov, and International Clinical Trials Registry Platform without language restrictions until October 2019 in addition to the reference lists of included studies. Field experts were also contacted.

      Study Eligibility Criteria

      Randomized or quasi-randomized controlled trials comparing any corticosteroids against each other or against placebo at any dose for preterm birth were included in the study.

      Methods

      Three researchers independently selected and extracted data and assessed the risk of bias of the included studies by using Early Review Organizing Software and Covidence software. Random-effects pairwise meta-analysis and Bayesian network meta-analysis were performed. The primary outcomes were chorioamnionitis, endometritis or puerperal sepsis, neonatal death, respiratory distress syndrome, and neurodevelopmental disability.

      Results

      A total of 45 trials (11,227 women and 11,878 infants) were included in the study. No clinical or statistical difference was found between dexamethasone and betamethasone in neonatal death (odds ratio, 1.05; 95% confidence interval, 0.62–1.84; moderate-certainty evidence), neurodevelopmental disability (odds ratio, 1.03; 95% confidence interval, 0.80–1.33; moderate-certainty evidence), intraventricular hemorrhage (odds ratio, 1.04; 95% confidence interval, 0.56–1.78); low-certainty evidence), or birthweight (+5.29 g; 95% confidence interval, −49.79 to 58.97; high-certainty evidence). There was no statistically significant difference, but a potentially clinically important effect was found between dexamethasone and betamethasone in chorioamnionitis (odds ratio, 0.70; 95% confidence interval, 0.45–1.06; moderate-certainty evidence), fetal death (odds ratio, 0.81; 95% confidence interval, 0.24–2.41; low-certainty evidence), puerperal sepsis (odds ratio, 2.04; 95% confidence interval, 0.72–6.06; low-certainty evidence), and respiratory distress syndrome (odds ratio, 1.34; 95% confidence interval, 0.96–2.11; moderate-certainty evidence). Meta-regression, subgroup, and sensitivity analyses did not reveal important changes regarding the main analysis.

      Conclusion

      Corticosteroids have proven effective for most neonatal and child-relevant outcomes compared with placebo or no treatment for women at risk of preterm birth. No important difference was found on neonatal death, neurodevelopmental disability, intraventricular hemorrhage, and birthweight between corticosteroids, and there was no statistically significant difference, but a potentially important difference was found in chorioamnionitis, fetal death, endometritis or puerperal sepsis, and respiratory distress syndrome. Further research is warranted to improve the certainty of evidence and inform health policies.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology MFM
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Chawanpaiboon S.
        • Vogel J.P.
        • Moller A.B.
        • et al.
        Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis.
        Lancet Glob Health. 2019; 7: e37-e46
        • Platt M.J.
        Outcomes in preterm infants.
        Public Health. 2014; 128: 399-403
        • United Nations Department of Economic and Social Affairs, United Nations Children’s Fund, World Health Organization, World Bank Group
        Levels and trends in child mortality: 2017 report.
        (Available at:) (Accessed December 20, 2020)
        • Glass H.C.
        • Costarino A.T.
        • Stayer S.A.
        • Brett C.M.
        • Cladis F.
        • Davis P.J.
        Outcomes for extremely premature infants.
        Anesth Analg. 2015; 120: 1337-1351
        • Crowley P.
        Prophylactic corticosteroids for preterm birth.
        Cochrane Database Syst Rev. 2000; CD000065
        • WHO ACTION Trials Collaborators
        The World Health Organization ACTION-I (Antenatal corticosteroids for Improving Outcomes in preterm Newborns) Trial: a multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries.
        Trials. 2019; 20: 507
        • World Health Organization
        WHO recommendations on interventions to improve preterm birth outcomes.
        (Available at:) (Accessed December 20, 2020)
        • World Health Organization, United Nations Population Fund, United Nations Children's Fund, The World Bank
        Managing complications in pregnancy and childbirth: a guide for midwives and doctors.
        (Available at:) (Accessed December 20, 2020)
        • Brownfoot F.C.
        • Gagliardi D.I.
        • Bain E.
        • Middleton P.
        • Crowther C.A.
        Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth.
        Cochrane Database Syst Rev. 2013; CD006764
        • Roberts D.
        • Brown J.
        • Medley N.
        • Dalziel S.R.
        Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.
        Cochrane Database Syst Rev. 2017; 3CD004454
        • Roberts D.
        • Dalziel S.
        Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.
        Cochrane Database Syst Rev. 2006; CD004454
        • Crowther C.A.
        • Ashwood P.
        • Andersen C.C.
        • et al.
        Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial.
        Lancet Child Adolesc Health. 2019; 3: 769-780
        • Mirzamoradi M.
        • Hasani Nejhad F.
        • Jamali R.
        • Heidar Z.
        • Bakhtiyari M.
        Evaluation of the effect of antenatal betamethasone on neonatal respiratory morbidities in late preterm deliveries (34-37 weeks).
        J Matern Fetal Neonatal Med. 2020; 33: 2533-2540
        • Ontela V.
        • Dorairajan G.
        • Bhat V.B.
        • Chinnakali P.
        Effect of antenatal steroids on respiratory morbidity of late preterm newborns: a randomized controlled trial.
        J Trop Pediatr. 2018; 64: 531-538
        • Hutton B.
        • Salanti G.
        • Caldwell D.M.
        • et al.
        The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
        Ann Intern Med. 2015; 162: 777-784
        • Binder L.M.
        • Iverson G.L.
        • Brooks B.L.
        To err is human: “abnormal” neuropsychological scores and variability are common in healthy adults.
        Arch Clin Neuropsychol. 2009; 24: 31-46
        • Ciapponi A.
        • Glujovsky D.
        • Bardach A.
        • García Martí S.
        • Comande D.
        EROS: a new software for early stage of systematic reviews.
        . 2011; 14: PA564
      1. Covidence systematic review software. Melbourne, Commonwealth of Australia: Veritas Health Innovation.

        • Higgins J.
        • Green S.
        • Chandler J.
        • et al.
        Cochrane handbook for systematic reviews of interventions version 5.1.
        (Available at:) (Accessed December 20, 2020)
        • Chaimani A.
        • Caldwell D.M.
        • Li T.
        • Higgins J.P.
        • Salanti G.
        Chapter 11. Undertaking network meta-analyses.
        in: Higgins J. Thomas J. Chandler J. Cochrane handbook for systematic reviews of interventions version 6. John Wiley & Sons, Chichester, United Kingdom2016
        • Higgins J.P.
        • Thompson S.G.
        Quantifying heterogeneity in a meta-analysis.
        Stat Med. 2002; 21: 1539-1558
        • Baker S.G.
        • Kramer B.S.
        The transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C?.
        BMC Med Res Methodol. 2002; 2: 13
        • Higgins J.P.
        • Jackson D.
        • Barrett J.K.
        • Lu G.
        • Ades A.E.
        • White I.R.
        Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies.
        Res Synth Methods. 2012; 3: 98-110
        • Veroniki A.A.
        • Vasiliadis H.S.
        • Higgins J.P.
        • Salanti G.
        Evaluation of inconsistency in networks of interventions.
        Int J Epidemiol. 2013; 42: 332-345
        • Dias S.
        • Welton N.J.
        • Caldwell D.M.
        • Ades A.E.
        Checking consistency in mixed treatment comparison meta-analysis.
        Stat Med. 2010; 29: 932-944
        • Turner R.M.
        • Davey J.
        • Clarke M.J.
        • Thompson S.G.
        • Higgins J.P.
        Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews.
        Int J Epidemiol. 2012; 41: 818-827
        • The World Bank
        World Bank country and lending groups.
        (Accessed December 20, 2020)
        • Chaimani A.
        • Higgins J.P.
        • Mavridis D.
        • Spyridonos P.
        • Salanti G.
        Graphical tools for network meta-analysis in STATA.
        PLoS One. 2013; 8: e76654
        • Trinquart L.
        • Attiche N.
        • Bafeta A.
        • Porcher R.
        • Ravaud P.
        Uncertainty in treatment rankings: reanalysis of network meta-analyses of randomized trials.
        Ann Intern Med. 2016; 164: 666-673
        • Veroniki A.A.
        • Straus S.E.
        • Rücker G.
        • Tricco A.C.
        Is providing uncertainty intervals in treatment ranking helpful in a network meta-analysis?.
        J Clin Epidemiol. 2018; 100: 122-129
        • Veroniki A.A.
        • Straus S.E.
        • Fyraridis A.
        • Tricco A.C.
        The rank-heat plot is a novel way to present the results from a network meta-analysis including multiple outcomes.
        J Clin Epidemiol. 2016; 76: 193-199
        • Lunn D.J.
        • Thomas A.
        • Best N.
        • Spiegelhalter D.
        WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility.
        Stat Comput. 2000; 10: 325-337
      2. Review Manager (RevMan) [Computer program] version 53. The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen2014
        • Puhan M.A.
        • Schünemann H.J.
        • Murad M.H.
        • et al.
        A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis.
        BMJ. 2014; 349: g5630
        • Brignardello-Petersen R.
        • Bonner A.
        • Alexander P.E.
        • et al.
        Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis.
        J Clin Epidemiol. 2018; 93: 36-44
        • Schünemann H.
        • Vist G.
        • Higgins J.
        • et al.
        Interpreting results and drawing conclusions.
        in: Higgins J. Thomas J. Chandler J. Cochrane handbook for systematic reviews of interventions version 6.0. John Wiley & Sons, Chichester, United Kingdom2019
      3. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome.
        Am J Obstet Gynecol. 1981; 141: 276-287
        • Amorim M.M.R.
        • Santos L.C.
        • Faúndes A.
        Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia.
        Am J Obstet Gynecol. 1999; 180: 1283-1288
        • Attawattanakul N.
        • Tansupswatdikul P.
        Effects of antenatal dexamethasone on respiratory distress in late preterm infant: a randomized controlled trial.
        J Obstet Gynaecol. 2015; 23: 25-33
        • Balci O.
        • Ozdemir S.
        • Mahmoud A.S.
        • Acar A.
        • Colakoglu M.C.
        The effect of antenatal steroids on fetal lung maturation between the 34th and 36th week of pregnancy.
        Gynecol Obstet Invest. 2010; 70: 95-99
        • Block M.F.
        • Kling O.R.
        • Crosby W.M.
        Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant.
        Obstet Gynecol. 1977; 50: 186-190
        • Cararach V.
        • Botet F.
        • Sentis J.
        • Carmona F.
        A multicenter, prospective and randomized study in premature rupture of membranes (PROM). Maternal and perinatal complications.
        Int J Gynaecol Obstet. 1991; 36: 267-269
        • Carlan S.J.
        • Parsons M.
        • O’Brien W.F.
        • Krammer J.
        Pharmacologic pulmonary maturation in preterm premature rupture of membranes.
        Am J Obstet Gynecol. 1991; 164: 371
        • Chen C.Y.
        • Wang K.G.
        • Chang T.Y.
        • Chen C.P.
        • Loo J.H.
        Effects of antenatal betamethasone and dexamethasone in preterm neonates.
        Taiwan J Obstet Gynecol. 2005; 44: 247-251
        • Danesh A.
        • Janghorbani M.
        • Khalatbari S.
        Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: a randomized trial comparing betamethasone and dexamethasone.
        J Res Med Sci. 2012; 17: 911-917
        • Doran T.A.
        • Swyer P.
        • MacMurray B.
        • et al.
        Results of a double-blind controlled study on the use of betamethasone in the prevention of respiratory distress syndrome.
        Am J Obstet Gynecol. 1980; 136: 313-320
        • Egerman R.S.
        • Walker R.A.
        • Mercer B.M.
        • Doss J.L.
        • Sibai B.M.
        • Andersen R.A.
        Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester.
        Am J Obstet Gynecol. 1998; 179: 1234-1236
        • Elimian A.
        • Garry D.
        • Figueroa R.
        • Spitzer A.
        • Wiencek V.
        • Quirk J.G.
        Antenatal betamethasone compared with dexamethasone (betacode trial): a randomized controlled trial.
        Obstet Gynecol. 2007; 110: 26-30
        • Fekih M.
        • Chaieb A.
        • Sboui H.
        • Denguezli W.
        • Hidar S.
        • Khairi H.
        [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study].
        Tunis Med. 2002; 80: 260-265
        • Gamsu H.R.
        • Mullinger B.M.
        • Donnai P.
        • Dash C.H.
        Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial.
        Br J Obstet Gynaecol. 1989; 96: 401-410
        • Garite T.J.
        • Rumney P.J.
        • Briggs G.G.
        • et al.
        A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks’ gestation.
        Am J Obstet Gynecol. 1992; 166: 646-651
      4. Sakamoto S, Tojo S, Nakayama T. Gynecology and obstetrics: proceedings of the IX World Congress of Gynecology and Obstetrics, Tokyo, October 25-31, 1979/Editors, Shoichi Sakamoto, Shimpei Tojo, and Tetsuya Nakayama. Amsterdam: Excerpta Medica; 1980. Print. Available at: https://catalog.library.vanderbilt.edu/permalink/01VAN_INST/13em2a7/alma991023098319703276. Accessed December 20, 2019.

        • Gyamfi-Bannerman C.
        • Thom E.A.
        • Blackwell S.C.
        • et al.
        Antenatal betamethasone for women at risk for late preterm delivery.
        N Engl J Med. 2016; 374: 1311-1320
        • Kari M.A.
        • Hallman M.
        • Eronen M.
        • et al.
        Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study.
        Pediatrics. 1994; 93: 730-736
        • Khandelwal M.
        • Chang E.
        • Hansen C.
        • Hunter K.
        • Milcarek B.
        Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial.
        Am J Obstet Gynecol. 2012; 206: 201.e1-201.e11
        • Khazardoust S.
        • Javadian P.
        • Salmanian B.
        • et al.
        A clinical randomized trial on endocervical inflammatory cytokines and betamethasone in prime-gravid pregnant women at risk of preterm labor.
        Iran J Immunol. 2012; 9: 199-207
        • Lewis D.F.
        • Brody K.
        • Edwards M.S.
        • Brouillette R.M.
        • Burlison S.
        • London S.N.
        Preterm premature ruptured membranes: a randomized trial of steroids after treatment with antibiotics.
        Obstet Gynecol. 1996; 88: 801-805
        • Liggins G.C.
        • Howie R.N.
        A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.
        Pediatrics. 1972; 50: 515-525
        • Lopez L.
        • Rojas L.
        • Rodriguez V.
        • Sanchez J.
        Use of corticoids in preterm pregnancy with premature rupture of membranes.
        Rev Colomb Obstet Ginecol. 1989; 40: 147-151
        • Magee L.A.
        • Dawes G.S.
        • Moulden M.
        • Redman C.W.
        A randomised controlled comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate.
        Br J Obstet Gynaecol. 1997; 104: 1233-1238
        • Mansouri M.
        • Seyedolshohadaei F.
        • Company F.
        • Setare S.
        • Mazhari S.
        Effect of antenatal betamethasone on prevention of respiratory distress syndrome among neonates with gestational age of 35-36 weeks.
        J Gorgan Univ Med Sci. 2010; 12: 18-23
        • Morales W.J.
        • Angel J.L.
        • O’Brien W.F.
        • Knuppel R.A.
        Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study.
        Obstet Gynecol. 1989; 73: 721-726
        • Mulder E.J.
        • Derks J.B.
        • Visser G.H.
        Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone.
        Br J Obstet Gynaecol. 1997; 104: 1239-1247
        • Mushkat Y.
        • Ascher-Landsberg J.
        • Keidar R.
        • Carmon E.
        • Pauzner D.
        • David M.P.
        The effect of betamethasone versus dexamethasone on fetal biophysical parameters.
        Eur J Obstet Gynecol Reprod Biol. 2001; 97: 50-52
        • Nelson L.H.
        • Meis P.J.
        • Hatjis C.G.
        • Ernest J.M.
        • Dillard R.
        • Schey H.M.
        Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management.
        Obstet Gynecol. 1985; 66: 55-58
      5. 8th Annual Meeting of the Society of Perinatal Obstetricians January 1988. Available at: https://els-jbs-prod-cdn.jbs.elsevierhealth.com/pb/assets/raw/Health%20Advance/journals/ymob/1988_SMFM_Abstracts.pdf. Accessed December 20, 2019.

        • Pattinson R.C.
        • Makin J.D.
        • Funk M.
        • et al.
        The use of dexamethasone in women with preterm premature rupture of membranes—a multicentre, double-blind, placebo-controlled, randomised trial. Dexiprom Study Group.
        S Afr Med J. 1999; 89: 865-870
        • Porto A.M.F.
        • Coutinho I.C.
        • Correia J.B.
        • Amorim M.M.R.
        Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial.
        BMJ. 2011; 342: d1696
        • Qublan H.S.
        • Malkawi H.Y.
        • Hiasat M.S.
        • et al.
        The effect of antenatal corticosteroid therapy on pregnancies complicated by premature rupture of membranes.
        Clin Exp Obstet Gynecol. 2001; 28: 183-186
        • Rotmensch S.
        • Liberati M.
        • Vishne T.H.
        • Celentano C.
        • Ben-Rafael Z.
        • Bellati U.
        The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomized trial.
        Acta Obstet Gynecol Scand. 1999; 78: 493-500
        • Schutte M.F.
        • Treffers P.E.
        • Koppe J.G.
        • Breur W.
        The influence of betamethasone and orciprenaline on the incidence of respiratory distress syndrome in the newborn after preterm labour.
        Br J Obstet Gynaecol. 1980; 87: 127-131
        • Senat M.V.
        • Minoui S.
        • Multon O.
        • Fernandez H.
        • Frydman R.
        • Ville Y.
        Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labour: a randomised study.
        Br J Obstet Gynaecol. 1998; 105: 749-755
        • Shanks A.
        • Gross G.
        • Shim T.
        • Allsworth J.
        • Sadovsky Y.
        • Bildirici I.
        Administration of steroids after 34 weeks of gestation enhances fetal lung maturity profiles.
        Am J Obstet Gynecol. 2010; 203: 47.e1-47.e5
        • Silver R.K.
        • Vyskocil C.
        • Solomon S.L.
        • Ragin A.
        • Neerhof M.G.
        • Farrell E.E.
        Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks’ gestation.
        Obstet Gynecol. 1996; 87: 683-691
        • Subtil D.
        • Tiberghien P.
        • Devos P.
        • et al.
        Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomized trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone.
        Am J Obstet Gynecol. 2003; 188: 524-531
        • Taeusch H.W.
        • Frigoletto F.
        • Kitzmiller J.
        • et al.
        Risk of respiratory distress syndrome after prenatal dexamethasone treatment.
        Pediatrics. 1979; 63: 64-72
        • Teramo K.
        • Hallman M.
        • Raivio K.O.
        Maternal glucocorticoid in unplanned premature labor. Controlled study on the effects of betamethasone phosphate on the phospholipids of the gastric aspirate and on the adrenal cortical function of the newborn infant.
        Pediatr Res. 1980; 14: 326-329
        • Urban R.
        • Lemancewicz A.
        • Przepieść J.
        • Urban J.
        • Kretowska M.
        Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal Doppler flow velocity waveforms.
        Eur J Obstet Gynecol Reprod Biol. 2005; 120: 170-174
        • Hong S.
        • Lee S.M.
        • Kwak D.W.
        • et al.
        Effects of antenatal corticosteroids in twin neonates with late preterm birth (ACTWIN [Antenatal corticosteroids in TWIN late preterm neonates] trial): study protocol for a randomized controlled trial.
        BMC Pregnancy Childbirth. 2019; 19: 114
        • Seoul National University Hospital
        Effects of ACS in twin with LPB: study protocol for a RCT.
        (Available at:) (Accessed November 18, 2019)
        • Ahmadu Bello University Teaching Hospital
        Effect of antenatal corticosteroids on neonatal morbidity.
        (Available at:) (Accessed December 20, 2019)
        • Cartwright R.
        • Crowther C.
        • Anderson P.
        • Harding J.
        • Doyle L.
        • McKinlay C.
        Influence of fetal growth restriction on neurocognitive function after repeat antenatal betamethasone: secondary analysis of a randomised trial.
        J Paediatr Child Health. 2019; 55: 12-13
        • Cartwright R.D.
        • Crowther C.A.
        • Anderson P.J.
        • Harding J.E.
        • Doyle L.W.
        • McKinlay C.J.D.
        Association of fetal growth restriction with neurocognitive function after repeated antenatal betamethasone treatment vs placebo: secondary analysis of the ACTORDS randomized clinical trial.
        JAMA Network Open. 2019; 2e187636
        • Schmitz T.
        • Alberti C.
        • Ursino M.
        • Baud O.
        • Aupiais C.
        • BETADOSE Study Group and the GROG (Groupe de Recherche en Gynécologie Obstétrique)
        Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (BETADOSE).
        BMC Pregnancy Childbirth. 2019; 19: 67
        • Vogel J.P.
        • Oladapo O.T.
        • Pileggi-Castro C.
        • et al.
        Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials.
        BMJ Glob Health. 2017; 2: e000398
        • Althabe F.
        • Belizán J.M.
        • McClure E.M.
        • et al.
        A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial.
        Lancet. 2015; 385: 629-639
        • Jobe A.H.
        • Milad M.A.
        • Peppard T.
        • Jusko W.J.
        Pharmacokinetics and pharmacodynamics of intramuscular and oral betamethasone and dexamethasone in reproductive age women in India.
        Clin Transl Sci. 2020; 13: 391-399
        • Lee V.R.
        • Kaimal A.J.
        • Caughey A.B.
        Cost-effectiveness of antenatal late preterm steroids.
        Am J Obstet Gynecol. 2017; 216: S233
        • National Institute for Health and Care Excellence
        NICE guideline. Preterm labour and birth.
        (Available at:) (Accessed December 22, 2020)
        • Committee on Obstetric Practice
        Committee Opinion no. 713: antenatal corticosteroid therapy for fetal maturation.
        Obstet Gynecol. 2017; 130: e102-e109
        • Mukerji A.
        • Shah V.
        • Shah P.S.
        Periventricular/intraventricular hemorrhage and neurodevelopmental outcomes: a meta-analysis.
        Pediatrics. 2015; 136: 1132-1143
        • Gotardo J.W.
        • Volkmer N.F.V.
        • Stangler G.P.
        • Dornelles A.D.
        • Bohrer B.B.A.
        • Carvalho C.G.
        Impact of periintraventricular haemorrhage and periventricular leukomalacia in the neurodevelopment of preterms: a systematic review and meta-analysis.
        PLoS One. 2019; 14e0223427
        • Saigal S.
        • Doyle L.W.
        An overview of mortality and sequelae of preterm birth from infancy to adulthood.
        Lancet. 2008; 371: 261-269
        • Zhang H.
        • Liu J.
        • Liu T.
        • Wang Y.
        • Dai W.
        Antenatal maternal medication administration in preventing respiratory distress syndrome of premature infants: a network meta-analysis.
        Clin Respir J. 2018; 12: 2480-2490
        • Gonzalez Garay A.G.
        • Reveiz L.
        • Velasco Hidalgo L.
        • Solis Galicia C.
        Ambroxol for women at risk of preterm birth for preventing neonatal respiratory distress syndrome.
        Cochrane Database Syst Rev. 2014; CD009708
        • Vogel J.P.
        • Souza J.P.
        • Gülmezoglu A.M.
        • et al.
        Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and newborn Health.
        Lancet. 2014; 384: 1869-1877
        • United Nations Commission, Born Too Soon Care Antenatal Corticosteroids Working Group
        Dexamethasone versus betamethasone as an antenatal corticosteroid (ACS).
        (Available at:) (Accessed December 15, 2020)
        • Gyamfi-Bannerman C.
        • Zupancic J.A.F.
        • Sandoval G.
        • et al.
        Cost-effectiveness of antenatal corticosteroid therapy vs no therapy in women at risk of late preterm delivery: a secondary analysis of a randomized clinical trial.
        JAMA Pediatr. 2019; 173: 462-468
        • Rosenbloom J.I.
        • Lewkowitz A.K.
        • Sondgeroth K.E.
        • et al.
        Antenatal corticosteroid administration in late-preterm gestations: a cost-effectiveness analysis.
        J Matern Fetal Neonatal Med. 2020; 33: 2109-2115
        • Greensides D.
        • Robb-McCord J.
        • Noriega A.
        • Litch J.A.
        Antenatal corticosteroids for women at risk of imminent preterm birth in 7 sub-Saharan African Countries: a policy and implementation landscape analysis.
        Glob Health Sci Pract. 2018; 6: 644-656